JNJ-6617 - J&J
ziftomenib (KO-539) - Kura Oncology
Blincyto (blinatumomab) - Astellas, Amgen
luveltamab tazevibulin (STRO-002) - Sutro Biopharma
Venclexta (venetoclax) - Roche, AbbVie
SAR443579 - Sanofi
Besponsa (inotuzumab ozogamicin) - Pfizer, UCB
imatinib - Generic mfg.
Iclusig (ponatinib) - Takeda, Otsuka
revumenib (SNDX-5613) - Syndax Pharma
WU CART 007 - Wugen
https://www.icksh.org/file/ICKSH2024_Abstract_Book.pdf
 
Michel Zwaan
 
Jan 17, 2024
 
Prev Next